Earnings Preview For Catalyst Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Catalyst Pharmaceuticals (NASDAQ:CPRX) is scheduled to release its quarterly earnings report on 2024-02-28, with analysts expecting an EPS of $0.26. The company's past earnings performance shows a mix of beats and misses, with the share price reacting variably. Shares were trading at $14.18 as of February 26, marking a 7.47% decline over the last 52 weeks. Investors will be keenly watching for not just the earnings results but also the company's guidance for future growth.
February 27, 2024 | 6:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Catalyst Pharmaceuticals is expected to report an EPS of $0.26 for the quarter. Past earnings have shown mixed results, with the stock price reacting variably. Currently, shares are down 7.47% over the last year.
Given Catalyst Pharmaceuticals' mixed past earnings performance and the current downward trend in its stock price, the upcoming earnings report and particularly the guidance for future quarters will be crucial. However, the impact on the stock price in the short term is uncertain, as past performance shows both positive and negative reactions to earnings announcements.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100